EpiThany, Inc. is dedicated to the advancement of innovative therapies to improve the lives of cancer patients. EpiThany's groundbreaking technology enables the targeting of a multitude of tumor antigens across a spectrum of cancers, driving Th1-selective (tumor-eradicating) immune responses. EpiThany was launched in 2014 on the R&D platform developed at the Tumor Vaccine Group (TVG) at the University of Washington by pioneering cancer vaccine researcher Nora Disis, scientific co-founder of the company.
View Top Employees from epithany , inc.| Website | http://www.epithany.com |
| Revenue | $8 million |
| Employees | View employees |
| Founded | 2014 |
| Phone | (206) 992-3047 |
| Industry | Business Services General, Biotechnology, Business Services, Science and Engineering, Therapeutics, Health Care |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54171 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies |
Looking for a particular epithany , inc. employee's phone or email?
epithany , inc. Questions
The epithany , inc. annual revenue was $8 million in 2024.
epithany , inc. is based in Washington, District of Columbia.
The NAICS codes for epithany , inc. are [54171, 541714, 541, 5417, 54].
The SIC codes for epithany , inc. are [87, 873].
Related Companies
